EU & UK Conclude Decentralised Procedure Approval for Bijuva® (Estradiol & Progesterone) Capsules for Hormone Replacement Therapy

Go back to EU & UK Conclude Decentralised Procedure Approval for Bijuva® (Estradiol & Progesterone) Capsules for Hormone Replacement Therapy
THERAPEUTICSMD, Inc. (NASDAQ: TXMD) Delayed: 1.09 -0.02 (1.8%)
Previous Close $1.11    52 Week High $11.26 
Open $1.11    52 Week Low $4.39 
Day High $1.12    P/E N/A 
Day Low $1.08    EPS $-0.22 
Volume 13,193,171